Daniel T. Scavilla's Insider Trades & SAST Disclosures
Daniel T. Scavilla's most recent trade in DENTSPLY Sirona Inc was a trade of 3,385 Common Stock done . Disclosure was reported to the exchange on Feb. 24, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Daniel T. Scavilla.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| DENTSPLY Sirona Inc | Daniel T. Scavilla | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2025 | 3,385 | 3,385 (0%) | 0% | 0 | Common Stock | |
| Globus Medical Inc - Ordin... | Daniel T. Scavilla | Director, President, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2025 | 140,000 | 140,000 | - | - | Stock Option (Right to Buy Class A Common Stock) | |
| Globus Medical Inc - Ordin... | Daniel T. Scavilla | Director, President, CEO | Sale of securities on an exchange or to another person at price $ 85.00 per share. | 21 Nov 2024 | 130,000 | 0 (0%) | 0% | 85 | 11,050,000 | Class A Common Stock |
| Globus Medical Inc - Ordin... | Daniel T. Scavilla | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 43.58 per share. | 21 Nov 2024 | 80,000 | 130,000 (0%) | 0% | 43.6 | 3,486,400 | Class A Common Stock |
| Globus Medical Inc - Ordin... | Daniel T. Scavilla | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2024 | 80,000 | 0 | - | - | Stock Option (Right to Buy Class A Common Stock) | |
| Globus Medical Inc - Ordin... | Daniel T. Scavilla | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2024 | 50,000 | 0 | - | - | Stock Option (Right to Buy Class A Common Stock) | |
| Globus Medical Inc - Ordin... | Daniel T. Scavilla | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 43.77 per share. | 21 Nov 2024 | 50,000 | 50,000 (0%) | 0% | 43.8 | 2,188,500 | Class A Common Stock |
| Globus Medical Inc - Ordin... | Daniel T. Scavilla | Director, President, CEO | Sale of securities on an exchange or to another person at price $ 80.02 per share. | 06 Nov 2024 | 60,000 | 0 (0%) | 0% | 80.0 | 4,801,200 | Class A Common Stock |
| Globus Medical Inc - Ordin... | Daniel T. Scavilla | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 43.77 per share. | 06 Nov 2024 | 30,000 | 60,000 (0%) | 0% | 43.8 | 1,313,100 | Class A Common Stock |
| Globus Medical Inc - Ordin... | Daniel T. Scavilla | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.27 per share. | 06 Nov 2024 | 30,000 | 30,000 (0%) | 0% | 26.3 | 788,100 | Class A Common Stock |
| Globus Medical Inc - Ordin... | Daniel T. Scavilla | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Nov 2024 | 30,000 | 50,000 | - | - | Stock Option (Right to Buy Class A Common Stock) | |
| Globus Medical Inc - Ordin... | Daniel T. Scavilla | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Nov 2024 | 30,000 | 0 | - | - | Stock Option (Right to Buy Class A Common Stock) | |
| Globus Medical Inc - Ordin... | Daniel Scavilla T. | Director, President, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2024 | 140,000 | 140,000 | - | - | Stock Option (Right to Buy Class A Common Stock) | |
| Globus Medical Inc - Ordin... | Daniel T. Scavilla | Director, President, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Oct 2023 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy Class A Common Stock) | |
| Globus Medical Inc - Ordin... | Daniel T. Scavilla | Director, President, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2023 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy Class A Common Stock) | |
| Globus Medical Inc - Ordin... | Daniel T. Scavilla | Director, President, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Apr 2022 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy Class A Common Stock) | |
| Globus Medical Inc - Ordin... | Daniel T. Scavilla | EVP, Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2022 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy Class A Common Stock) | |
| Globus Medical Inc - Ordin... | Daniel T. Scavilla | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 78.41 per share. | 02 Jul 2021 | 99,600 | 400 (0%) | 0% | 78.4 | 7,809,636 | Class A Common Stock |
| Globus Medical Inc - Ordin... | Daniel T. Scavilla | EVP, Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.27 per share. | 02 Jul 2021 | 50,000 | 100,000 (0%) | 0% | 26.3 | 1,313,500 | Class A Common Stock |
| Globus Medical Inc - Ordin... | Daniel T. Scavilla | EVP, Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jul 2021 | 50,000 | 30,000 | - | - | Stock Option (Right to Buy Class A Common Stock) | |
| Globus Medical Inc - Ordin... | Daniel T. Scavilla | EVP, Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jul 2021 | 50,000 | 0 | - | - | Stock Option (Right to buy Class A Common Stock) | |
| Globus Medical Inc - Ordin... | Daniel T. Scavilla | EVP, Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 25.52 per share. | 02 Jul 2021 | 50,000 | 50,000 (0%) | 0% | 25.5 | 1,276,000 | Class A Common Stock |
| Globus Medical Inc - Ordin... | Daniel T. Scavilla | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 78.97 per share. | 02 Jul 2021 | 400 | 0 (0%) | 0% | 79.0 | 31,588 | Class A Common Stock |
| Globus Medical Inc - Ordin... | Daniel T. Scavilla | EVP, Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2021 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy Class A Common Stock) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges